avatar
DNDN怎么了?# Stock
u*n
1
版上这些小药股的pick从何而来?
有版友在里面上班?
avatar
a*1
2
I know they have been bleeding money because their drug did not sell well.
It looks like they will be running out of money very soon and there is no
hope of turning around due to the high cost of making the drug, thus low
profit margin and competition from JNJ of course.
The high cost is due to the specific of their drug and it is quite
complicated to make. One on side, you can argue that it is complicated and
that is why DNDN is losing money, on the other hand, you can argue that
their know-how would make them a target right now, especially with the
current market cap.
It is a high risk one and I don't own the stock. Don't like to gamble anyway
. But I think it is a target to be acquired soon because they will be more
willing to sell and someone would love to have get the know-how and the
infrastructure.

【在 u**********n 的大作中提到】
: 版上这些小药股的pick从何而来?
: 有版友在里面上班?

相关阅读
logo
联系我们隐私协议©2024 redian.news
Redian新闻
Redian.news刊载任何文章,不代表同意其说法或描述,仅为提供更多信息,也不构成任何建议。文章信息的合法性及真实性由其作者负责,与Redian.news及其运营公司无关。欢迎投稿,如发现稿件侵权,或作者不愿在本网发表文章,请版权拥有者通知本网处理。